14-day Premium Trial Subscription Sign Up For FreeGet Free

Capricor Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 80.12. In total, the insiders bought 7 093 355 and sold 211 865 CAPR shares in the last 100 trades.

Insider Power

(Last 100 transactions)
80.12
Buy 7 093 355 Shares
Sell 211 865 Shares

Historical Insider Trades

Date Type Action Person Amount
Mar 05, 2025 Common Stock Sell Marban Linda 12 500
Mar 03, 2025 Common Stock Buy Marban Linda 25 000
Mar 03, 2025 Stock Option (Right to Buy) Sell Marban Linda 25 000
Mar 03, 2025 Common Stock Buy Bergmann Anthony 2 500
Mar 03, 2025 Stock Option (Right to Buy) Sell Bergmann Anthony 2 500
Mar 03, 2025 Common Stock Buy Litvack Frank 25 000
Mar 03, 2025 Common Stock Sell Litvack Frank 2 543
Mar 03, 2025 Stock Option (Right to Buy) Sell Litvack Frank 25 000
Mar 03, 2025 Common Stock Buy Dunbar George W Jr 750
Mar 03, 2025 Stock Option (Right to Buy) Sell Dunbar George W Jr 750
Feb 27, 2025 Common Stock Buy Collier Earl M Jr 750
Feb 27, 2025 Stock Option (Right to Buy) Sell Collier Earl M Jr 750
Jan 02, 2025 Stock Option (Right to Buy) Buy Litvack Frank 50 000
Jan 02, 2025 Stock Option (Right to Buy) Buy Bergmann Anthony 75 000
Jan 02, 2025 Stock Option (Right to Buy) Buy Bergmann Anthony 6 170
Jan 02, 2025 Common Stock Buy Bergmann Anthony 3 342
Jan 02, 2025 Stock Option (Right to Buy) Buy Krasney Karen 60 000
Jan 02, 2025 Stock Option (Right to Buy) Buy Marban Linda 210 000
Jan 02, 2025 Stock Option (Right to Buy) Buy Marban Linda 34 962
Jan 02, 2025 Stock Option (Right to Buy) Buy Kelliher Mike 11 940
Jan 02, 2025 Stock Option (Right to Buy) Buy Kelliher Mike 5 750
Jan 02, 2025 Stock Option (Right to Buy) Buy Kelliher Mike 1 440
Jan 02, 2025 Stock Option (Right to Buy) Buy Auwaerter Paul Gisbert 11 940
Jan 02, 2025 Stock Option (Right to Buy) Buy Auwaerter Paul Gisbert 5 750
Jan 02, 2025 Stock Option (Right to Buy) Buy Auwaerter Paul Gisbert 1 440
Click to get the best stock tips daily for free!
ABOUT CAPRICOR THERAPEUTICS
Capricor Therapeutics
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph...
GOLDEN STAR
Ticker Change Signal Date
NOV
$12.25
11.51% Jun 04
G
GTM
$9.57
0.94% Jun 02
TAC
$8.90
24.61% May 12
UAA
$5.84
13.01% May 09
HBM
$7.41
30.77% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE